Molecular Pharmacology

Inverse agonism is not a type of drug-receptor interaction. Agonism, antagonism, and partial agonism are all types of drug-receptor interactions.

Pharmacokinetics is the study of the absorption, distribution, metabolism, and excretion of drugs.

Phase III is not a phase of drug metabolism. Phase I and Phase II are the two main phases of drug metabolism.

Pharmacodynamics is the study of the effects of drugs on living organisms.

Potentiation is not a type of pharmacodynamic effect. Stimulation, inhibition, and synergism are all types of pharmacodynamic effects.

Cmax is the maximum concentration of a drug in the body after administration.

Particle size is not a factor that affects drug absorption. Route of administration, solubility, and pH of the gastrointestinal tract are all factors that affect drug absorption.

Tmax is the time it takes for a drug to reach its maximum concentration in the body after administration.

Acetyltransferases are not a type of drug metabolism enzyme. Cytochrome P450, UDP-glucuronosyltransferases, and sulfotransferases are all types of drug metabolism enzymes.

AUC is the area under the curve of a drug concentration-time graph.

Blood-brain barrier is not a factor that affects drug distribution. Protein binding, lipid solubility, and pH of the tissue are all factors that affect drug distribution.

Half-life is the time it takes for a drug to be eliminated from the body.

Pulmonary excretion is not a type of drug excretion. Renal excretion, hepatic excretion, and biliary excretion are all types of drug excretion.

Clinical pharmacology is the study of the safety and efficacy of drugs in humans.

Phase IV is not a type of clinical trial. Phase I, Phase II, and Phase III are all types of clinical trials.